Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.

Abstract excerpt

Uveal melanoma (UM) is the most common primary malignant intraocular tumor in adults. Although primary UM can be effectively controlled, a significant proportion of cases (40% or more) eventually develop distant metastases, commonly in the liver. Metastatic UM remains a lethal disease with limited treatment options. The initiation of UM is typically attributed to activating mutations in GNAQ or GNA11. The...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immunotherapy
• Share to Melanoma
• Share to Molecular Targeted Therapy